Diligence memo · auto-generated · as of July 3, 2026

U.S. NeuroSurgical Holdings, Inc.

U.S. NeuroSurgical Holdings, Inc. looks fair against its niche peers and is active on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

U.S. NeuroSurgical Holdings, Inc. operates in Other Health Care, based in Ontario.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

U.S. NeuroSurgical Holdings, Inc. has raised $10M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $5.0M on 2024-01-16.

Most recent recorded round closed around 2025-07-31.

Valuation (modeled)modeled

Provath models U.S. NeuroSurgical Holdings, Inc. at approximately $16M (range $6.4M–$28M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.00× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 11 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round was 1.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 76% of Other Health Care peers (5377 compared).

Modeled value ranks above 44% of those peers.

Closest niche peers: HelloJoy, Inc., Maui Imaging, Inc., Celltrio, Inc., Medmo, Inc., Vertical Orthopaedics, Inc..

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.